This J.P. Morgan document, marked 'CONFIDENTIAL' and 'HOUSE_OVERSIGHT_022352', is a presentation slide explaining a wealth transfer strategy using an Intentionally Defective Grantor Trust (IDGT). It details a four-step process where a 'Grantor' sells an asset to an IDGT for a note, which allows the remaining trust assets to eventually pass to 'Beneficiaries' free of gift tax. The document also suggests using 'cascading GRATs' to enhance the benefits of this strategy.
| Name | Role | Context |
|---|---|---|
| Grantor | Asset seller and trust creator |
The individual who sells an asset to an Intentionally Defective Grantor Trust (IDGT) in exchange for a promissory not...
|
| Beneficiaries | Recipients of trust assets |
The individuals who receive the remaining assets from the IDGT, free of gift tax, after the promissory note to the Gr...
|
| Name | Type | Context |
|---|---|---|
| J.P.Morgan |
The firm whose logo appears on the document, likely the author of this financial planning presentation.
|
|
| IDGT (Intentionally Defective Grantor Trust) |
A type of trust used for estate planning. It is treated as a grantor trust for income tax purposes but not for estate...
|
|
| GRATs (Grantor Retained Annuity Trusts) |
Mentioned as a complementary strategy ('cascading GRATs') to enhance the benefits of the IDGT, where remainders from ...
|
|
| HOUSE_OVERSIGHT |
The identifier 'HOUSE_OVERSIGHT_022352' at the bottom of the page suggests this document is part of a collection held...
|
"Sell asset at fair market value to the trust in return for a promissory note bearing interest at proper AFR* based upon term of loan"Source
"After note is paid off, remaining assets in trust are available, free of gift tax, for beneficiaries**"Source
"To enhance the potential benefits consider funding a series of cascading GRATs – the remainders can be added to the IDGT"Source
"If Grantor dies before note is satisfied, the fair market value of the note is includible in grantor's estate."Source
Complete text extracted from the document (1,174 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document